How to find Anktiva in stock near you (tools + tips)

How to Find Anktiva in Stock Near You

Being prescribed Anktiva (nogapendekin alfa inbakicept-pmln) is a hopeful step in your bladder cancer treatment. But finding where to actually get it can feel overwhelming. Anktiva isn't available at regular pharmacies — it's a specialty medication that requires a specific ordering process.

This guide walks you through the tools and tips you need to find Anktiva in stock near you in 2026.

Understanding How Anktiva Is Distributed

Before you start searching, it helps to understand how Anktiva works differently from most medications:

• It's not a retail pharmacy drug. You won't find Anktiva at CVS, Walgreens, or your local pharmacy.
• It's administered in a clinical setting. Anktiva is given as an intravesical instillation — delivered directly into your bladder through a catheter at your doctor's office or treatment center.
• It's ordered through specialty distributors. Healthcare providers order Anktiva through Cencora (formerly AmerisourceBergen) using the buy-and-bill model.
• It requires BCG. Anktiva must be administered in combination with BCG, which is also in limited supply.

This means your search for Anktiva is really a search for the right provider and treatment center — not the right pharmacy.

Step 1: Use MedFinder to Search for Availability

The fastest way to check Anktiva availability is through MedFinder.com. MedFinder helps patients locate medications that are hard to find, including specialty oncology drugs like Anktiva.

Simply search for "Anktiva" and enter your location. MedFinder will show you treatment centers and providers in your area that have access to this medication.

Step 2: Contact the ImmunityBio CARE Program

ImmunityBio offers the CARE program, a dedicated support service for Anktiva patients and providers. Contact them at:

• Phone: 1-877-ANKTIVA (1-877-265-8482)
• Hours: Monday–Friday, 8:00 AM–8:00 PM ET

The CARE program can:

• Help you find treatment centers that carry Anktiva
• Investigate your insurance benefits
• Support prior authorization submissions
• Provide financial assistance information
• Guide you through claim denials and appeals

This should be one of your first calls. The CARE team has direct knowledge of which facilities are currently ordering and stocking Anktiva.

Step 3: Ask Your Urologist or Oncologist

Your urologist or urologic oncologist is your best advocate. If they've prescribed Anktiva, they likely already know which treatment centers in your region can administer it. Ask them:

• "Does your practice currently stock or order Anktiva?"
• "Can you refer me to a center that administers Anktiva with BCG?"
• "Do you have access to BCG for the combination treatment?"

If your current provider doesn't have Anktiva access, they can refer you to a urologic oncologist at an academic medical center or major cancer center that does. For help finding the right doctor, see our guide on finding a doctor who prescribes Anktiva.

Step 4: Check With Major Cancer Centers

Large academic medical centers and NCI-designated cancer centers are most likely to have Anktiva available. These institutions typically:

• Have established specialty distributor relationships
• Employ urologic oncologists experienced with newer immunotherapies
• Have dedicated oncology pharmacy teams that manage specialty drug ordering
• May also have BCG supply access through priority allocation

If you live in a metropolitan area, start with the nearest academic medical center or comprehensive cancer center. If you're in a rural area, be prepared that you may need to travel for treatment.

Step 5: Verify BCG Availability Too

Remember that Anktiva is always used in combination with BCG. Even if a center has Anktiva, they also need BCG in stock. The ongoing BCG shortage (Merck is the sole U.S. supplier) means some centers have Anktiva but are rationing BCG.

When contacting a treatment center, ask specifically: "Do you currently have both Anktiva and BCG available for combination treatment?"

For more on the BCG shortage and how it affects your treatment, read our Anktiva shortage update for 2026.

Step 6: Get Your Insurance Sorted Early

Don't wait until you've found a provider to start the insurance process. Prior authorization for Anktiva can take days to weeks. Steps to take now:

1. Call your insurance company and ask if Anktiva (J-code J9028) is covered under your plan
2. Ask about prior authorization requirements and what documentation is needed
3. Have your doctor submit the prior authorization as early as possible
4. Contact the ImmunityBio CARE program for help navigating insurance requirements

For patients with commercial insurance, the copay assistance program may bring your cost down to as little as $100 per dose. Learn more in our guide on saving money on Anktiva.

Step 7: Consider Clinical Trials

If you're having difficulty accessing Anktiva through standard channels, clinical trials may be another option. ImmunityBio is running several trials involving Anktiva for expanded indications, including:

• Papillary-only BCG-unresponsive NMIBC
• Non-small cell lung cancer combinations
• Recombinant BCG trials that may provide an alternative BCG source

Ask your oncologist about trial eligibility or search ClinicalTrials.gov for "Anktiva" or "N-803" to find active studies near you.

What to Do If You Hit a Dead End

If you've tried everything and still can't access Anktiva, don't lose hope. Here are backup options:

• Ask about alternatives. Other FDA-approved options for BCG-unresponsive NMIBC include Pembrolizumab (Keytruda) and Nadofaragene firadenovec (Adstiladrin). See our full guide on alternatives to Anktiva.
• Contact patient advocacy organizations. Bladder cancer advocacy groups can connect you with resources and support.
• Get a second opinion. Another specialist may have different connections or access to the medication.

Related Articles

• Why Is Anktiva So Hard to Find?
• How to Check If a Pharmacy Has Anktiva in Stock
• What Is Anktiva? Uses, Dosage, and What You Need to Know
• Anktiva Shortage Update for 2026